CHANG JOSEPH Y 4

4 · NU SKIN ENTERPRISES, INC. · Filed Mar 3, 2022

Form 4

Period: 2022-03-02

Chief Scientific Officer

Transactions

Exercise/Conversion
Class A Common Stock
2022-03-02$30.63/sh+3,423$104,846→ 26,380 total
Sale
Class A Common Stock
2022-03-02$45.86/sh−2,500$114,650→ 23,880 total
Sale
Class A Common Stock
2022-03-02$46.53/sh−923$42,947→ 22,957 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2022-03-02−3,423→ 42,600 total
Exercise: $30.63Exp: 2023-03-02→ Class A Common Stock (3,423 underlying)

Holdings

Footnotes (5)

[F1]Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.24 to $46.18, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.35 to $46.63, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
[F4]This report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
[F5]Currently exercisable in full.

Documents

1 file